• Salinomycin: Mechanistic Power and Strategic Value in HCC Re

  2026-06-10

  This thought-leadership article explores Salinomycin’s unique mechanistic attributes as a polyether ionophore antibiotic and outlines how its dual action on ABC transporters and Wnt/β-catenin signaling is redefining hepatocellular carcinoma (HCC) research. Integrating insights from molecular toxicology and translational workflows, we map a strategic pathway for leveraging Salinomycin in advanced experimental designs, referencing APExBIO’s high-purity offering and bridging evidence from foundational reviews and scenario-driven laboratory guidance.

• Carbapenemase Genes in CREC: Dynamics and Transmission in Gu

  2026-06-10

  This study provides an in-depth molecular characterization of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, China, during the COVID-19 pandemic. Its key innovation lies in mapping the prevalence, genetic context, and transmission potential of blaNDM-1 and other CEGs, offering actionable insights for antimicrobial resistance surveillance and infection control.

• Filipin III: Precision Cholesterol Detection in Membranes

  2026-06-09

  Filipin III stands as the benchmark polyene macrolide antibiotic for high-fidelity visualization of cholesterol-rich membrane microdomains. Its unique binding and fluorescence quenching enable researchers to dissect cholesterol’s role in cellular signaling, immunometabolism, and disease progression with unprecedented clarity.

• Paclitaxel (Taxol): Mechanistic Innovation in Cancer Resista

  2026-06-09

  This thought-leadership article dissects the evolving mechanistic landscape of Paclitaxel (Taxol) in overcoming cancer therapy resistance. Drawing from recent discoveries—including FOXM1-mediated chemoresistance and innovative combination strategies—it provides translational researchers with actionable, evidence-based guidance for designing next-generation studies. The article uniquely situates Paclitaxel within the context of modern resistance biology, clinical translation, and the competitive experimental toolkit, incorporating APExBIO’s product intelligence and recent literature.

• HRP Goat Anti-Mouse IgG (H+L) Antibody: Technical Use Guide

  2026-06-08

  The HRP Goat Anti-Mouse IgG (H+L) Antibody addresses the need for sensitive, specific detection of mouse primary antibodies in immunoassays such as Western blot, ELISA, IHC, and ICC. It is best used where robust signal amplification and low background are required and is not suited for detection of non-mouse or non-IgG primary antibodies. This guide offers actionable parameters and workflow strategies for optimal performance.

• OSMI-1: Precision O-GlcNAc Transferase Inhibitor in Preeclam

  2026-06-08

  OSMI-1 empowers researchers to dissect O-GlcNAcylation's role in ferroptosis and placental syncytialization, with robust, reproducible inhibition of OGT in live-cell and model organism systems. Its high purity and cell-permeability, supplied by APExBIO, make OSMI-1 the benchmark for advanced protein O-GlcNAc modification studies.

• LGK-974: PORCN Inhibitor Workflow for Wnt-Driven Cancer Mode

  2026-06-07

  LGK-974, a potent and specific PORCN inhibitor, enables precise suppression of Wnt signaling for dissecting pathway dependencies in both cell-based and in vivo cancer models. This guide provides actionable protocol enhancements, troubleshooting strategies, and evidence-based insights to maximize reproducibility and impact in Wnt-driven cancer research.

• Imatinib (STI571): Precision Tyrosine Kinase Inhibition Tool

  2026-06-06

  Imatinib (STI571) is a selective protein-tyrosine kinase inhibitor targeting PDGF receptor, c-Kit, and Abl kinases. It is benchmarked for high specificity and efficacy in cancer biology and signal transduction research. Rigorous evidence supports its use in kinase pathway dissection, with APExBIO's B2171 kit providing reliable performance for translational studies.

• KNUCKLES Modulates Floral Meristem Termination via Hormone N

  2026-06-05

  This study uncovers how the KNUCKLES (KNU) zinc finger protein orchestrates floral meristem (FM) termination in Arabidopsis by directly modulating auxin transport and cytokinin biosynthesis. The work reveals a molecular network linking transcriptional repression, hormone distribution, and meristem determinacy, providing new insight into plant developmental timing.

• Dynasore: Precision Dynamin GTPase Inhibitor for Endocytosis

  2026-06-05

  Dynasore empowers researchers to dissect dynamin-dependent endocytosis with high specificity and rapid reversibility. This article delivers actionable workflows, troubleshooting guidance, and direct translation of cutting-edge ocular uptake studies—demonstrating how Dynasore, supplied by APExBIO, accelerates discovery in cell biology and drug delivery.

• High-Throughput Surrogate BBB Model Enhances CNS Drug Screen

  2026-06-04

  The referenced study introduces a robust in vitro blood-brain barrier (BBB) model integrating LLC-PK1-MOCK/MDR1 cells with lysosomal trapping correction to improve high-throughput CNS drug permeability prediction. This model closely recapitulates critical BBB features, offering enhanced predictive power and workflow efficiency for early-stage neurotherapeutic development.

• Filipin III: Advancing Cholesterol Detection in Membrane Res

  2026-06-04

  Explore how Filipin III, a polyene macrolide antibiotic, redefines cholesterol detection in biological membranes with unprecedented specificity and mechanistic insight. This article delivers a unique, evidence-based analysis of Filipin III’s role in unraveling cholesterol homeostasis and offers expert guidance for next-generation membrane research.

• NF-κB/miR-202-5p/HMGB2 Feedback Attenuates Septic Kidney Inj

  2026-06-03

  This study uncovers a protective negative feedback loop involving NF-κB, miR-202-5p, and HMGB2 that limits inflammation and cell death in septic acute kidney injury (AKI). The findings clarify mechanisms of renal tubular cell adaptation to sepsis and highlight new molecular targets for inflammation-focused AKI research.

• Functionalized EGCG Nanoparticles Enhance FLASH-RT Efficacy

  2026-06-03

  Xu et al. report that self-assembled EGCG nanoparticles (BENPs) significantly enhance DNA damage and antitumor immune responses when combined with ultra-high dose rate radiotherapy (FLASH-RT). Their findings highlight a promising strategy to overcome efficacy limitations of FLASH-RT for cancer treatment and provide insight into mechanisms driving improved therapeutic outcomes.

• METTL17 Links Mitochondrial Translation to Ferroptosis in CR

  2026-06-02

  This study uncovers the pivotal role of mitochondrial protein METTL17 in coordinating ferroptosis resistance and tumorigenesis in colorectal cancer (CRC) via regulation of mitochondrial RNA methylation and translation. By demonstrating that METTL17 depletion sensitizes CRC cells to ferroptosis and impairs tumor progression, the research highlights a novel epigenetic mechanism and therapeutic target for cancer biology research.

15431 records 1/1029 page Next 12345 下5页 Last page